{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T23:01:37Z","timestamp":1781737297710,"version":"3.54.5"},"reference-count":18,"publisher":"Norwegian Medical Association","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tidsskr Nor Legeforen","Tidsskriftet"],"published-print":{"date-parts":[[2012,2,7]]},"DOI":"10.4045\/tidsskr.10.1317","type":"journal-article","created":{"date-parts":[[2012,2,7]],"date-time":"2012-02-07T09:22:00Z","timestamp":1328606520000},"page":"288-91","source":"Crossref","is-referenced-by-count":3,"title":["Kj\u00f8nns- og aldersforskjeller ved bruk av psykofarmaka"],"prefix":"10.4045","volume":"132","author":[{"given":"Kjell Petter","family":"B\u00f8gwald","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ida","family":"Rudberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Tanum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helge","family":"Refsum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2479","reference":[{"key":"ref=1","doi-asserted-by":"crossref","unstructured":"Meibohm B, Beierle I, Derendorf H. How important are gender differences in pharmacokinetics? Clin Pharmacokinet 2002; 41: 329\u2009\u2013\u200942. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12036391&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.2165\/00003088-200241050-00002","DOI":"10.2165\/00003088-200241050-00002"},{"key":"ref=2","doi-asserted-by":"crossref","unstructured":"H\u00e4rtter S, Wetzel H, Hammes E et al. Nonlinear pharmacokinetics of fluvoxamine and gender differences. Ther Drug Monit 1998; 20: 446\u2009\u2013\u20099. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9712472&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1097\/00007691-199808000-00016","DOI":"10.1097\/00007691-199808000-00016"},{"key":"ref=3","doi-asserted-by":"crossref","unstructured":"Ronfeld RA, Tremaine LM, Wilner KD. Pharmacokinetics of sertraline and its N-demethyl metabolite in elderly and young male and female volunteers. Clin Pharmacokinet 1997; 32 (suppl 1): 22\u2009\u2013\u200930. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9068932&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.2165\/00003088-199700321-00004","DOI":"10.2165\/00003088-199700321-00004"},{"key":"ref=4","doi-asserted-by":"crossref","unstructured":"Reis M, Lundmark J, Bengtsson F. Therapeutic drug monitoring of racemic citalopram: a 5-year experience in Sweden, 1992\u2009\u2013\u20091997. Ther Drug Monit 2003; 25: 183\u2009\u2013\u200991. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12657912&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1097\/00007691-200304000-00007","DOI":"10.1097\/00007691-200304000-00007"},{"key":"ref=5","doi-asserted-by":"crossref","unstructured":"Reis M, Aamo T, Spigset O et al. Serum concentrations of antidepressant drugs in a naturalistic setting: compilation based on a large therapeutic drug monitoring database. Ther Drug Monit 2009; 31: 42\u2009\u2013\u200956. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=19077925&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1097\/FTD.0b013e31819114ea","DOI":"10.1097\/FTD.0b013e31819114ea"},{"key":"ref=6","unstructured":"Andersen S, Refsum H, Tanum L. Bruk av psykofarmaka - b\u00f8r serumkonsentrasjonen kontrolleres? Tidsskr Nor L\u00e6geforen 2004; 124: 2362-4. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15467801&dopt=Abstract"},{"key":"ref=7","doi-asserted-by":"crossref","unstructured":"Anderson GD. Sex and racial differences in pharmacological response: where is the evidence? Pharmacogenetics, pharmacokinetics, and pharmacodynamics. J Womens Health (Larchmt) 2005; 14: 19\u2009\u2013\u200929. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15692274&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1089\/jwh.2005.14.19","DOI":"10.1089\/jwh.2005.14.19"},{"key":"ref=8","doi-asserted-by":"crossref","unstructured":"Bebia Z, Buch SC, Wilson JW et al. Bioequivalence revisited: influence of age and sex on CYP enzymes. Clin Pharmacol Ther 2004; 76: 618\u2009\u2013\u200927. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15592333&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016\/j.clpt.2004.08.021","DOI":"10.1016\/j.clpt.2004.08.021"},{"key":"ref=9","unstructured":"WHO Collaborating Centre for Drug Statistics Methodology. ATC\/DDD Index 2012. www.whocc.no\/atc_ddd_index\/ (19.4.2010)."},{"key":"ref=10","unstructured":"Ogden CL, Fryar CD, Carroll MD et al. Mean body weight, height, and body mass index, United States 1960\u20132002. Adv Data 2004; nr. 347: 1\u2009\u2013\u200917."},{"key":"ref=11","unstructured":"Gross JL, Friedman R, Azevedo MJ et al. Effect of age and sex on glomerular filtration rate measured by 51Cr-EDTA. Braz J Med Biol Res 1992; 25: 129\u2009\u2013\u200934. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=1339508&dopt=Abstract"},{"key":"ref=12","doi-asserted-by":"crossref","unstructured":"Rademaker M. Do women have more adverse drug reactions? Am J Clin Dermatol 2001; 2: 349\u2009\u2013\u200951. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11770389&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.2165\/00128071-200102060-00001","DOI":"10.2165\/00128071-200102060-00001"},{"key":"ref=13","doi-asserted-by":"crossref","unstructured":"Vaswani M, Linda FK, Ramesh S. Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review. Prog Neuropsychopharmacol Biol Psychiatry 2003; 27: 85\u2009\u2013\u2009102. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12551730&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016\/S0278-5846(02)00338-X","DOI":"10.1016\/S0278-5846(02)00338-X"},{"key":"ref=14","doi-asserted-by":"crossref","unstructured":"Fabre LF Jr, Abuzzahab FS, Amin M et al. Sertraline safety and efficacy in major depression: a double-blind fixed-dose comparison with placebo. Biol Psychiatry 1995; 38: 592\u2009\u2013\u2009602. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8573661&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016\/0006-3223(95)00178-8","DOI":"10.1016\/0006-3223(95)00178-8"},{"key":"ref=15","doi-asserted-by":"crossref","unstructured":"Burke WJ, Gergel I, Bose A. Fixed-dose trial of the single isomer SSRI escitalopram in depressed outpatients. J Clin Psychiatry 2002; 63: 331\u2009\u2013\u20096. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12000207&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.4088\/JCP.v63n0410","DOI":"10.4088\/JCP.v63n0410"},{"key":"ref=16","doi-asserted-by":"crossref","unstructured":"Lingam R, Scott J. Treatment non-adherence in affective disorders. Acta Psychiatr Scand 2002; 105: 164\u2009\u2013\u200972. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11939969&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1034\/j.1600-0447.2002.1r084.x","DOI":"10.1034\/j.1600-0447.2002.1r084.x"},{"key":"ref=17","doi-asserted-by":"crossref","unstructured":"Demyttenaere K, Adelin A, Patrick M et al. Six-month compliance with antidepressant medication in the treatment of major depressive disorder. Int Clin Psychopharmacol 2008; 23: 36\u2009\u2013\u200942. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=18090506&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1097\/YIC.0b013e3282f1c1d8","DOI":"10.1097\/YIC.0b013e3282f1c1d8"},{"key":"ref=18","doi-asserted-by":"crossref","unstructured":"Castberg I, Westin AA, Spigset O. Does level of care, sex, age, or choice of drug influence adherence to treatment with antipsychotics? J Clin Psychopharmacol 2009; 29: 415\u2009\u2013\u200920. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=19745639&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1097\/JCP.0b013e3181b2fced","DOI":"10.1097\/JCP.0b013e3181b2fced"}],"container-title":["Tidsskrift for Den norske legeforening"],"original-title":[],"language":"no","deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:04:11Z","timestamp":1781654651000},"score":1,"resource":{"primary":{"URL":"https:\/\/tidsskriftet.no\/2012\/02\/originalartikkel\/kjonns-og-aldersforskjeller-ved-bruk-av-psykofarmaka"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2,7]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,2,7]]}},"URL":"https:\/\/doi.org\/10.4045\/tidsskr.10.1317","relation":{},"ISSN":["0029-2001","0807-7096"],"issn-type":[{"value":"0029-2001","type":"print"},{"value":"0807-7096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2,7]]}}}